USANA Health Sciences, Inc. $USNA reported third-quarter 2026 revenue of $205.9 million, down 3.6% from a year earlier, as gross profit slipped to $157.2 million. Operating profit came in at a loss of $1.4 million, while net loss attributable to common shareholders widened to $5.6 million, or $(0.30) per diluted share.
Cash generation remained positive, with operating cash flow of $12.0 million. The company ended the period with $178.9 million in cash and cash equivalents, up 23.1% year over year, while total liabilities fell to $138.4 million.
Additional quarter highlights included:
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
USANA Health Sciences, Inc. Insider Trading Activity
USANA Health Sciences, Inc. insiders have traded $USNA stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $USNA stock by insiders over the last 6 months:
- PAUL A. JONES (CHIEF PEOPLE OFFICER) has made 0 purchases and 2 sales selling 12,374 shares for an estimated $231,984.
- BRENT NEIDIG (CHIEF COMMERCIAL OFFICER) has made 0 purchases and 3 sales selling 7,513 shares for an estimated $147,768.
- G DOUG IIEKKING (CHIEF FINANCIAL OFFICER) sold 5,360 shares for an estimated $100,513
- JOHN TURMAN FLEMING sold 2,450 shares for an estimated $43,928
- GILBERT A FULLER sold 1,057 shares for an estimated $19,728
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
USANA Health Sciences, Inc. Hedge Fund Activity
We have seen 70 institutional investors add shares of USANA Health Sciences, Inc. stock to their portfolio, and 72 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CREATIVE PLANNING removed 417,971 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $6,048,040
- BLACKROCK, INC. added 363,773 shares (+30.6%) to their portfolio in Q2 2026, for an estimated $7,766,553
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 272,208 shares (+inf%) to their portfolio in Q2 2026, for an estimated $5,811,640
- NUVEEN, LLC removed 167,962 shares (-70.1%) from their portfolio in Q3 2026, for an estimated $2,430,410
- AQR CAPITAL MANAGEMENT LLC added 111,666 shares (+37.7%) to their portfolio in Q2 2026, for an estimated $2,384,069
- LAZARD ASSET MANAGEMENT LLC added 97,311 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,077,589
- PZENA INVESTMENT MANAGEMENT LLC removed 91,604 shares (-7.6%) from their portfolio in Q3 2026, for an estimated $1,325,509
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
